Ellen L. Carmichael’s editorial appeared in The Hayride on May 5, 2017. Carmichael formerly served as press secretary to now-Health and Human Services Secretary Tom Price, M.D. She is currently president of The Lafayette Company.
Read MoreAli Schroer wrote this editorial for the Washington Examiner on May 10, 2017.
Like millions of Americans, I take allergy medicine. A few years ago, my doctor urged me to bid farewell to my local pharmacy and instead buy my medication from an online Canadian drug store, where it was cheaper. What terrible advice! The website was counterfeit and sent me “medicine” that was anything but — causing me to get severely sick . . .
Read More
In an editorial published in the Philadelphia Inquirer, Louis J. Freeh, former director of the FBI and former federal judge, warns that allowing American citizens to purchase medicine from foreign countries puts them at risk from counterfeit drugs, would incentive criminal organizations to make counterfeit drugs, and places more stress on law enforcement efforts to combat the issue.
Read MoreGeorge Karavetsos, former head of the U.S. Food and Drug Administration’s Office of Criminal Investigations wrote this editorial for the Miami Herald on May 6, 2017.
Read MoreOn May 9th, the board of the Partnership for Safe Medicines sent the following letter to all members of the U.S. Senate. Dear Senator, The Partnership for Safe Medicines has dutifully studied the problem of counterfeit drugs in America for over a decade. We have examined court transcripts of prosecutions of counterfeiters, watched scientists test counterfeits…
Read More
A Greensboro, North Carolina news station, WFMY News2, is warning viewers that the Internet is filled with fake online pharmacies that sell counterfeit drugs. In the television segment accompanying the story, WFMY shared surveillance images of a suspected drop-shipper posting up to 80 packages of counterfeit medications a day. The U.S. Postal Inspector WFMY spoke…
Read More
Narinder Kaulder, head of Operations for River East, a company named in the Canada Drugs indictment, is currently fighting extradition from England on charges he was part of the conspiracy that sold counterfeit cancer medication to U.S. oncology clinics in 2012, the Daily Mail reports. According to the CanadaDrugs Indictment, lot number B6011 of Avastin that…
Read More
The Morning Consult recently published an op-ed by Libby Baney, the Executive Director of the Alliance for Safe Online Pharmacies (ASOP Global), a nonprofit dedicated to addressing the growing public health threat of illegal online pharmacies. In the piece, Ms. Baney stated that drug importation proposals are not a safe or effective way to address the rising cost of prescription drugs . . .
Read More
Ronald Piervincenzi, CEO of the U.S. Pharmacopeial Convention describes the dangerous flaws in any plan to open up U.S. borders to wholesale prescription medication importation from Canada.
Read More
The Washington Examiner recently ran an op-ed by Charlie Cichon, the Executive Director of the National Association of Drug Diversion Investigators. In it he explained how the opioid crisis will only be made worse if the U.S. allows drug importation.
Read More